Xeris Biopharma Inc. (XERS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Xeris Biopharma Inc.

    NASDAQ: XERS · Real-Time Price · USD
    8.18
    0.33 (4.20%)
    At close: Sep 26, 2025, 3:59 PM
    8.00
    -2.21%
    After-hours: Sep 26, 2025, 07:40 PM EDT

    Xeris Biopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 71.62M 67.45M 121.97M 67.27M
    Short-Term Investments
    		 n/a 5M n/a 35.16M
    Long-Term Investments
    		 4.12M n/a 4.35M n/a
    Other Long-Term Assets
    		 -4.81M 4.54M 267K 4.37M
    Receivables
    		 40.41M 39.2M 30.83M 17.46M
    Inventory
    		 48.17M 38.84M 24.73M 18.12M
    Other Current Assets
    		 7.45M n/a 9.29M n/a
    Total Current Assets
    		 167.66M 156.26M 186.82M 142.6M
    Property-Plant & Equipment
    		 28.21M 29.18M 28.38M 28.38M
    Goodwill & Intangibles
    		 121.78M 132.62M 124.6M 124.6M
    Total Long-Term Assets
    		 155.4M 166.34M 157.7M 157.7M
    Total Assets
    		 323.06M 322.6M 344.52M 344.52M
    Account Payables
    		 2.29M 11.56M 4.61M 8.92M
    Deferred Revenue
    		 n/a n/a 64.78M n/a
    Short-Term Debt
    		 15.1M 3.5M 1.58M n/a
    Other Current Liabilities
    		 39.75M 47.94M -12.32M 18.95M
    Total Current Liabilities
    		 100.44M 95.19M 73.62M 79.04M
    Long-Term Debt
    		 217.01M 190.93M 187.07M 88.07M
    Other Long-Term Liabilities
    		 1.97M 6.23M 25.72M 37.08M
    Total Long-Term Liabilities
    		 252.23M 234.19M 225.71M 130.09M
    Total Liabilities
    		 352.68M 329.38M 299.33M 299.33M
    Total Debt
    		 271.45M 229.19M 198.06M 88.07M
    Book Value
    		 -29.61M -6.78M 45.19M 45.19M
    Book Value Per Share
    		 -0.2 -0.05 0.33 0.57
    Common Stock
    		 15K 14K 14K 13K
    Retained Earnings
    		 -671.86M -617.02M -554.77M -460.11M
    Comprehensive Income
    		 -25K -25K -23K -31K
    Shareholders Equity
    		 -29.61M -6.78M 45.19M 95.23M
    Total Investments
    		 4.12M 5M 4.35M 35.16M

    Add to Watchlist